As per our latest research, the global prostate cancer diagnostics market size reached USD 5.43 billion in 2024, demonstrating robust growth driven by technological advancements and increased awareness of early cancer detection. The market is expected to expand at a CAGR of 11.2% from 2025 to 2033, projecting a value of USD 14.54 billion by 2033. This significant growth is primarily fueled by the rising prevalence of prostate cancer globally, the adoption of next-generation diagnostic modalities, and the integration of artificial intelligence (AI) in clinical workflows. https://growthmarketreports.com/report/prostate-cancer-diagnostics-market-global-industry-analysis